Coya yesterday reported their low dose Il-2 phase
Post# of 148190
(Total Views: 409)
Posted On: 10/30/2024 7:01:05 AM
Coya yesterday reported their low dose Il-2 phase 2 Alzheimer's results. Seems mixed results with lower dosage of treatment every four weeks providing a slowing in cognitive decline. Meanwhile, higher dosage of treatment every two weeks appeared no better than placebo. Stock down 28% on the news.
Coya announced the results of the investigator initiated trial simultaneously with the conference poster.
https://ir.coyatherapeutics.com/news/news-det...fault.aspx
Coya announced the results of the investigator initiated trial simultaneously with the conference poster.
https://ir.coyatherapeutics.com/news/news-det...fault.aspx
(2)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼